Monday, October 05, 2009

Memphis, Tennessee Gets First H1N1 "Swine Flu" Vaccine in the United States of America!

Why am I not surprised that my hometown of Memphis, Tennessee was the first place to receive the H1N1 "swine flu" vaccine? Memphis is always on the forefront of everything whether good or bad. Based on the ingredients in this mist vaccine, I fear that a pandemic may soon spread across my hometown city. I hope that my family and friends do not take this deadly vaccine.

Holly Smith has the honor of being the 1st person on record (aside from trial subjects who received H1N1 vaccines full of a squalene adjuvant) to receive the H1N1 vaccine. Let's check with Ms. Smith over the next few weeks and months to see the state of her health considering that she just received a nasal shot of LIVE H1N1 "swine flu" virus. I will pray for her and hope that she does not succumb to the live virus in the vaccine. You can read the package insert by clicking this sentence. However, if you are lazy, you can review some of the ingredients below from the package insert.

Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is a live monovalent vaccine for administration by intranasal spray...

Specific pathogen-free (SPF) eggs are inoculated with the reassortant strain and incubated to allow vaccine virus replication. The allantoic fluid of these eggs is harvested, pooled and then clarified by filtration. The virus is concentrated by ultracentrifugation and diluted with stabilizing buffer to obtain the final sucrose and potassium phosphate concentrations...

Each pre-filled refrigerated Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal sprayer contains a single 0.2 mL dose. Each 0.2 mL dose contains 106.5-7.5 FFU of the live attenuated influenza virus reassortant of the pandemic (H1N1) 2009 virus: A/California/7/2009 (H1N1)v. Each 0.2 mL dose also contains 0.188 mg/dose monosodium glutamate, 2.00 mg/dose hydrolyzed porcine gelatin, 2.42 mg/dose arginine, 13.68 mg/dose sucrose, 2.26 mg/dose dibasic potassium phosphate, 0.96 mg/dose monobasic potassium phosphate, and <0.015>

The tip attached to the sprayer is equipped with a nozzle that produces a fine mist that is primarily deposited in the nose and nasopharynx. Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is a colorless to pale yellow liquid and is clear to slightly cloudy.

Source: The Baltimore Sun ; FDA

1 comment:

reflux the chemist said...

I love the hubris and total hypocrisy surrounding this live attenuated vaccine... The "experts" claim that the chances of shedding the live virus is around 2%, although in the same breath, they warn us to "stay away from immuno-compromised individuals for 21 days" so if the chances are only 2% for spreading it, why is it so important to stay away from those people? Insanity. Like what you are doing with your blog, I subb'ed you on scribd as well..peace =0)